NASDAQ
05.08.26 | 20:44
8,060 US-Dollar
-3,59 % -0,300
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.07. | Profound Medical: Aktie nach Studiendaten und Erstattungsausblick auf "Strong Buy" hochgestuft | 1 | Investing.com Deutsch | ||
| 27.07. | Profound Medical stock upgraded to Strong Buy on trial data, reimbursement outlook | 1 | Investing.com | ||
| 24.07. | Profound Medical Corp (2): Profound finds no penile length change after Tulsa | 1 | Stockwatch | ||
| 24.07. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 24.07. | Profound Medical Corp.: Robotic Radical Prostatectomy Comes Up 'Short' in CAPTAIN Trial | 4 | GlobeNewswire (USA) | ||
| 17.07. | Profound Medical Corp (2): Profound Medical to release Q2 results on Aug. 6 | 1 | Stockwatch | ||
| 15.07. | Stocks in Play: Profound Medical Corp. | - | Baystreet.ca | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| 15.07. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.07. | Profound Medical Corp.: Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026 | 2 | GlobeNewswire (USA) | ||
| 22.06. | Profound Medical Corp. (PROF) Dropped Despite High Potential | 1 | Insider Monkey | ||
| 18.05. | Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High? | 15 | Zacks | ||
| 15.05. | Profound Medical Corp (2): Profound, Telix form partnership on prostate imaging | 4 | Stockwatch | ||
| 14.05. | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Profound Medical Corp.: Profound Medical Annual General and Special Meeting of Shareholders Voting Results | 562 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General... ► Artikel lesen | |
| 07.05. | Profound Medical Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.05. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 17.04. | Profound Medical Corp (2): Profound to release Q1 results, host call May 7 | 1 | Stockwatch | ||
| 14.04. | Stocks in Play: Profound Medical Corp. | 1 | Baystreet.ca | ||
| 14.04. | Profound Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 01.04. | Profound Medical Corp.: Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting | 1 | GlobeNewswire (USA) |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 3,450 | 0,00 % | Plus Therapeutics Inc.: Cerenome Launches as an Integrated CNS Oncology Company | HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), today announces that its corporate rebrand to Cerenome will be completed as scheduled. Effective... ► Artikel lesen | |
| ORGANON | 11,725 | -0,26 % | Organon: $81 Million Jada Gain Lifts GAAP Profit 68% As Adjusted Earnings Fall 29% | ||
| QUIDELORTHO | 15,355 | +0,75 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| NANO-X IMAGING | 1,005 | -6,07 % | Nano-X Imaging Q2 2026 Earnings Preview | ||
| ROCKWELL MEDICAL | 7,300 | -3,57 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 1,700 | -9,57 % | Morning Market Movers: Nuwellis, T3 Defense, Capricor Therapeutics, PN Smart Energy See Big Swings | DEERFIELD (dpa-AFX) - At 8:45 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,095 | +4,46 % | Jefferies senkt Kursziel für Procept BioRobotics nach verfehlten Eingriffszahlen | ||
| NEURONETICS | 2,040 | +2,26 % | Neuronetics and Jorey Chernett Announce Shared Vision | ||
| PULSE BIOSCIENCES | 32,000 | -3,61 % | Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRX | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 28, 2026, driven by key catalysts including positive quarterly results.Incyte Corporation (INCY)Incyte is a... ► Artikel lesen | |
| OPTIMIZERX | 6,930 | +1,17 % | OptimizeRx Corporation: OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer | WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage... ► Artikel lesen | |
| PAVMED | 4,190 | -8,62 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 10,300 | -0,96 % | Orthofix Medical beats top-line and bottom-line estimates; updates FY26 outlook | ||
| OWLET | 5,540 | +3,75 % | Owlet Announces New $25 Million Credit Facility With Wells Fargo | ||
| QTREX QUANTUM | 1,060 | +0,95 % | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | ||
| PICARD MEDICAL | 3,720 | -13,49 % | Picard Medical, Inc.: Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026 |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 8,060 Euro und damit -3,59 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.